Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
580.52 USD | +0.83% | -2.71% | -3.25% |
Dec. 18 | Fed's gift to markets | |
Dec. 18 | Goldman Sachs Upgrades MSCI to Buy From Neutral, Adjusts Price Target to $723 From $617 | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.56B | 1.7B | 2.04B | 2.25B | 2.53B | |||||
Total Revenues | 1.56B | 1.7B | 2.04B | 2.25B | 2.53B | |||||
Cost of Goods Sold, Total | 288M | 292M | 359M | 404M | 447M | |||||
Gross Profit | 1.27B | 1.4B | 1.68B | 1.84B | 2.08B | |||||
Selling General & Admin Expenses, Total | 321M | 332M | 377M | 408M | 428M | |||||
Stock-Based Compensation (IS) | - | 379K | 1.42M | 738K | 346K | |||||
R&D Expenses | 98.33M | 101M | 112M | 107M | 132M | |||||
Depreciation & Amortization - (IS) | 30M | 29.8M | 28.9M | 26.89M | 21.01M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 49.41M | 56.94M | 64.58M | 91.08M | 114M | |||||
Other Operating Expenses | 15M | - | - | - | - | |||||
Other Operating Expenses, Total | 514M | 520M | 583M | 634M | 696M | |||||
Operating Income | 756M | 883M | 1.1B | 1.21B | 1.39B | |||||
Interest Expense, Total | -148M | -156M | -160M | -172M | -187M | |||||
Interest And Investment Income | 16.4M | 5.03M | 1.5M | 11.77M | 34.48M | |||||
Net Interest Expenses | -132M | -151M | -158M | -160M | -152M | |||||
Currency Exchange Gains (Loss) | -4M | -2.8M | -1.9M | 500K | -4.5M | |||||
Other Non Operating Income (Expenses) | 49K | 1.9M | 6.86M | -2.78M | -761K | |||||
EBT, Excl. Unusual Items | 620M | 731M | 949M | 1.05B | 1.23B | |||||
Merger & Related Restructuring Charges | - | - | -6.87M | -4.06M | -2.43M | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | 143M | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | - | -24.4M | -705K | -477K | |||||
Other Unusual Items | -16.79M | -44.93M | -59.1M | - | - | |||||
EBT, Incl. Unusual Items | 603M | 686M | 858M | 1.04B | 1.37B | |||||
Income Tax Expense | 39.67M | 84.4M | 132M | 173M | 220M | |||||
Earnings From Continuing Operations | 564M | 602M | 726M | 871M | 1.15B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 564M | 602M | 726M | 871M | 1.15B | |||||
Net Income - (IS) | 564M | 602M | 726M | 871M | 1.15B | |||||
Preferred Dividend and Other Adjustments | - | - | - | - | - | |||||
Net Income to Common Incl Extra Items | 564M | 602M | 726M | 871M | 1.15B | |||||
Net Income to Common Excl. Extra Items | 564M | 602M | 726M | 871M | 1.15B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 6.66 | 7.19 | 8.8 | 10.78 | 14.45 | |||||
Basic EPS - Continuing Operations | 6.66 | 7.19 | 8.8 | 10.78 | 14.45 | |||||
Basic Weighted Average Shares Outstanding | 84.64M | 83.72M | 82.51M | 80.75M | 79.46M | |||||
Net EPS - Diluted | 6.59 | 7.12 | 8.7 | 10.72 | 14.39 | |||||
Diluted EPS - Continuing Operations | 6.59 | 7.12 | 8.7 | 10.72 | 14.39 | |||||
Diluted Weighted Average Shares Outstanding | 85.54M | 84.52M | 83.48M | 81.22M | 79.84M | |||||
Normalized Basic EPS | 4.58 | 5.46 | 7.18 | 8.12 | 9.67 | |||||
Normalized Diluted EPS | 4.53 | 5.41 | 7.1 | 8.07 | 9.62 | |||||
Dividend Per Share | 2.52 | 2.92 | 3.64 | 4.58 | 5.52 | |||||
Payout Ratio | 39.55 | 40.95 | 41.66 | 42.84 | 38.39 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 821M | 947M | 1.17B | 1.3B | 1.48B | |||||
EBITA | 791M | 917M | 1.14B | 1.27B | 1.46B | |||||
EBIT | 756M | 883M | 1.1B | 1.21B | 1.39B | |||||
EBITDAR | 856M | 980M | 1.2B | 1.33B | 1.51B | |||||
Effective Tax Rate - (Ratio) | 6.58 | 12.3 | 15.4 | 16.6 | 16.1 | |||||
Current Domestic Taxes | 38.33M | 69.61M | 183M | 68.82M | 134M | |||||
Current Foreign Taxes | 22.1M | 70.44M | 60.77M | 68.02M | 102M | |||||
Total Current Taxes | 60.44M | 140M | 244M | 137M | 236M | |||||
Deferred Domestic Taxes | -15.94M | -53.42M | -106M | 40.51M | -2.54M | |||||
Deferred Foreign Taxes | -4.82M | -2.23M | -5.58M | -4.08M | -12.72M | |||||
Total Deferred Taxes | -20.77M | -55.64M | -111M | 36.44M | -15.26M | |||||
Normalized Net Income | 388M | 457M | 593M | 655M | 768M | |||||
Interest on Long-Term Debt | 152M | 164M | 167M | 172M | 187M | |||||
Non-Cash Pension Expense | 4.1M | 4.67M | 5.78M | 6.24M | 5.32M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 215M | 216M | 243M | 265M | 276M | |||||
General and Administrative Expenses | 107M | 115M | 133M | 142M | 151M | |||||
Research And Development Expense From Footnotes | 113M | 124M | 150M | 135M | 174M | |||||
Net Rental Expense, Total | 35.6M | 32.8M | 30.6M | 29.7M | 28.73M | |||||
Imputed Operating Lease Interest Expense | 14.45M | 12.1M | 9.95M | 9.08M | 9.23M | |||||
Imputed Operating Lease Depreciation | 21.15M | 20.7M | 20.65M | 20.62M | 19.5M | |||||
Stock-Based Comp., COGS (Total) | 11.19M | 14.52M | 17.28M | 15.4M | 19.45M | |||||
Stock-Based Comp., R&D Exp. (Total) | 5.97M | 7.34M | 7.91M | 6.86M | 9.62M | |||||
Stock-Based Comp., S&M Exp. (Total) | 14.94M | 13.54M | 14.41M | 14.22M | 17.39M | |||||
Stock-Based Comp., G&A Exp. (Total) | 11.99M | 19.83M | 17.46M | 20.83M | 26.23M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | - | 379K | 1.42M | 789K | 346K | |||||
Total Stock-Based Compensation | 44.09M | 55.62M | 58.49M | 58.09M | 73.04M |